Cue biopharma to present at the 2022 american society of clinical oncology (asco) annual meeting

Boston, may 26, 2022 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate targeted t cells directly within the patient's body, announced today it will give a poster presentation at the american society of clinical oncology (asco) annual meeting to be held in-person june 3–7 at the mccormick place convention center in chicago, illinois and virtually.
CUE Ratings Summary
CUE Quant Ranking